VTYX
Ventyx Biosciences Inc
NASDAQ · Pharmaceuticals
$13.96
+0.02 (+0.14%)
Open$13.92
Previous Close$13.94
Day High$13.96
Day Low$13.91
52W High$25.00
52W Low$0.78
Volume—
Avg Volume2.11M
Market Cap1.00B
P/E Ratio—
EPS$-1.50
SectorPharmaceuticals
Analyst Ratings
Strong Buy
15 analysts
Price Target
+352.4% upside
Current
$13.96
$13.96
Target
$63.16
$63.16
$39.88
$63.16 avg
$74.20
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 27.43M | 24.73M | 29.85M |
| Net Income | 6.42M | 4.69M | 6.83M |
| Profit Margin | 23.4% | 19.0% | 22.9% |
| EBITDA | 7.71M | 7.29M | 9.18M |
| Free Cash Flow | 5.17M | 5.81M | 4.69M |
| Rev Growth | -7.8% | +2.8% | +7.3% |
| Debt/Equity | 0.43 | 0.48 | 0.56 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,058.18 | +3.66% | 48.5 | 1.00T |
| JNJ | Johnson & Johnson | $239.99 | +0.93% | 21.6 | 578.21B |
| MRK | Merck & Co. Inc. | $121.93 | +1.82% | 16.6 | 302.63B |
| PFE | Pfizer Inc. | $27.22 | +2.76% | 19.9 | 154.76B |
| BMY | Bristol-Myers Squibb Co | $61.99 | +4.15% | 17.9 | 126.20B |
| ZTS | Zoetis Inc | $127.42 | +0.54% | 21.5 | 56.95B |